The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoneda, Y.
Right arrow Articles by Yoshida, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoneda, Y.
Right arrow Articles by Yoshida, R.
The Journal of Immunology, 1998, 160: 6012-6017.
Copyright © 1998 by The American Association of Immunologists

The Role of T Cells in Allografted Tumor Rejection: IFN-{gamma} Released from T Cells Is Essential for Induction of Effector Macrophages in the Rejection Site1

Yukio Yoneda2 and Ryotaro Yoshida3

Department of Cell Biology, Osaka Bioscience Institute, Suita, Osaka, Japan

Allografted Meth A tumor rejection is T cell dependent, but T cells are inactive toward the allograft; rather, the main effector cells are allograft-induced macrophages (AIM) with MHC haplotype specificity. Here, we examined the role of T cells in the induction of AIM in the rejection site. On day 4.5 after i.p. transplantation of Meth A fibrosarcoma cells to C57BL/6 (B6) mice, we obtained a kind of precursor of AIM (pro-AIM) from the transplantation site by an enrichment technique involving adherence to serum-coated dishes. The noncytotoxic pro-AIM-rich population put into a diffusion chamber became cytotoxic against Meth A cells after 2 days in the peritoneal cavity of an untreated B6 mouse. Similar activation of the chambered B6 pro-AIM-rich population occurred in IFN-{gamma} -/- B6 mice, whereas there was no activation when chambers containing an IFN-{gamma} -/- mouse-derived pro-AIM-rich population were placed in normal or IFN-{gamma} -/- mice, suggesting that IFN-{gamma} is involved in the activation. RT-PCR experiments demonstrated that among bulk infiltrates T cells were the major producer of IFN-{gamma}; and most of the cells in a T cell-eliminated pro-AIM population in a diffusion chamber kept for 2 days in a B6 mouse did not become AIM. Furthermore, IFN-{gamma} -/- B6 mice could not reject allografted Meth A tumor cells, whereas the grafts were rejected by i.p. injections of IFN-{gamma} into the mutant mice. These results indicate that IFN-{gamma} released from allograft-induced T cells is essential for both the activation of a kind of pro-AIM to AIM in the transplantation site and the rejection of an allografted tumor.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Nomi, J. Tashiro-Yamaji, Y. Yamamoto, S. Miura-Takeda, M. Miyoshi-Higashino, T. Takahashi, H. Azuma, H. Ueda, Y. Katsuoka, T. Kubota, et al.
Acute Rejection of Allografted CTL-Susceptible Leukemia Cells from Perforin/Fas Ligand Double-Deficient Mice
J. Immunol., August 15, 2007; 179(4): 2180 - 2186.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. Utermohlen, C. Schulze-Garg, G. Warnecke, R. Gugel, J. Lohler, and W. Deppert
Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells
J. Virol., November 15, 2001; 75(22): 10593 - 10602.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Diamond and R. G. Gill
An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts
J. Immunol., July 1, 2000; 165(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yoshida, Y. Yoneda, M. Kuriyama, and T. Kubota
IFN-{gamma}- and Cell-to-Cell Contact-Dependent Cytotoxicity of Allograft-Induced Macrophages Against Syngeneic Tumor Cells and Cell Lines: An Application of Allografting to Cancer Treatment
J. Immunol., July 1, 1999; 163(1): 148 - 154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.